Anebulo is a biotech company developing novel solutions for people suffering from cannabinoid overdose and substance addiction.
Anebulo Pharmaceuticals has raised $994K in total funding. The most recent round was Grant. The last funding was announced in September 2025.
Anebulo Pharmaceuticals's investors include Merida Capital Holdings, National Institute on Drug Abuse (NIDA), 22NW, LP.
Anebulo Pharmaceuticals is headquartered in Austin, United States.
Anebulo is a biotech company developing novel solutions for people suffering from cannabinoid overdose and substance addiction.
Anebulo Pharmaceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anebulo Pharmaceuticals — Funding & Investors." VCBacked, September 2, 2025, https://www.vcbacked.co/company/anebulo-pharmaceuticals. Accessed November 14, 2026.
VCBacked. (2025). Anebulo Pharmaceuticals — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/anebulo-pharmaceuticals
{{cite web |title=Anebulo Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/anebulo-pharmaceuticals |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Anebulo Pharmaceuticals? Request a listing update